Non-Alcoholic Steatohepatitis (NASH) Survey

Market: Pharma & Healthcare

Global, 8 pages report, published by Informa

Report ThumbnailMarch-2017
Datamonitor conducted a 4-question survey of 42 United States and 40 European (based in France, Germany, Italy and United Kingdom) gastroenterologists to gauge their views on late-stage clinical candidates in non-alcoholic steatohepatitis (NASH), including Ocaliva (ICPT), elafibranor (GNFTF) and selonsertib (GILD), and their projected use of these drugs if FDA-approved.


Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all repor

Read More
  • Survey
Read More

Please select a license type


Related Products

InformaNon-Alcoholic Steatohepatitis (NASH) SurveyProduct ThumbnailNon-Alcoholic Steatohepatitis (NASH) Survey, Industry ReportProduct #: 770014
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2021 Global Market Analyst. All Rights Reserved